IMP
Process View
cell substrate junction assembly
The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cell substrate junction assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.997 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.983 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.950 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.940 | Rat | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.917 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.883 | ||
| EGFR | epidermal growth factor receptor | 0.882 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.843 | ||
| S100B | S100 calcium binding protein B | 0.832 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.808 | ||
| FN1 | fibronectin 1 | 0.788 | Mouse | |
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.773 | ||
| NCK2 | NCK adaptor protein 2 | 0.734 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.708 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.642 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.610 | Human | |
| FLNA | filamin A, alpha | 0.579 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.536 | Mouse | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.495 | ||
| S100A8 | S100 calcium binding protein A8 | 0.451 | Human | |
| S100A6 | S100 calcium binding protein A6 | 0.448 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.447 | Human | |
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.445 | Worm | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.408 | Human | |
| S100A1 | S100 calcium binding protein A1 | 0.402 | Human | |
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.383 | ||
| ENG | endoglin | 0.382 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.363 | ||
| NRP1 | neuropilin 1 | 0.353 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.334 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.314 | ||
| PXN | paxillin | 0.295 | Human Mouse | |
| EPHA2 | EPH receptor A2 | 0.291 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.262 | Human | |
| ZYX | zyxin | 0.245 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.242 | ||
| PLEC | plectin | 0.225 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.224 | ||
| S100A4 | S100 calcium binding protein A4 | 0.224 | Human | |
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.221 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.216 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.212 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.211 | ||
| BMP2 | bone morphogenetic protein 2 | 0.207 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.195 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.193 | ||
| SFN | stratifin | 0.182 | ||
| ANGPT2 | angiopoietin 2 | 0.179 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.174 | ||
| HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.164 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.163 | ||
| ITGB4 | integrin, beta 4 | 0.150 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.148 | ||
| SMAD2 | SMAD family member 2 | 0.144 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.131 | ||
| EPHA7 | EPH receptor A7 | 0.131 | Human | |
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.129 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.126 | Human | |
| EFNA1 | ephrin-A1 | 0.123 | Human | |
| GHR | growth hormone receptor | 0.122 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.110 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.109 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.107 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.104 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.100 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.099 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.096 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.093 | Human | |
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.092 | ||
| SMAD7 | SMAD family member 7 | 0.092 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.090 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.084 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.083 | ||
| TCF4 | transcription factor 4 | 0.078 | ||
| ZNF746 | zinc finger protein 746 | 0.076 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.076 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.074 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.071 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.071 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.068 | ||
| ITGA6 | integrin, alpha 6 | 0.068 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.067 | Human | |
| GRB10 | growth factor receptor-bound protein 10 | 0.064 | ||
| S100A2 | S100 calcium binding protein A2 | 0.064 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.063 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.063 | ||
| CALD1 | caldesmon 1 | 0.061 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.058 | ||
| BMP1 | bone morphogenetic protein 1 | 0.058 | ||
| PTRF | polymerase I and transcript release factor | 0.058 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.057 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.056 | ||
| S100A11 | S100 calcium binding protein A11 | 0.055 | Human | |
| LDLR | low density lipoprotein receptor | 0.055 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.054 | ||
| LMNA | lamin A/C | 0.054 | ||
| KITLG | KIT ligand | 0.053 | ||
| PDGFC | platelet derived growth factor C | 0.053 | ||
| GDF5 | growth differentiation factor 5 | 0.049 | ||
| ACVR1 | activin A receptor, type I | 0.049 | Human | |
| ANGPT1 | angiopoietin 1 | 0.048 | ||
| AREG | amphiregulin | 0.048 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.048 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.048 | ||
| MYOZ1 | myozenin 1 | 0.047 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.047 | ||
| RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 0.047 | ||
| TSC2 | tuberous sclerosis 2 | 0.046 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.045 | Human | |
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 0.045 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.045 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.043 | ||
| DST | dystonin | 0.043 | ||
| JUP | junction plakoglobin | 0.042 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.041 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.041 | Human | |
| ANGPTL4 | angiopoietin-like 4 | 0.041 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.041 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.040 | ||
| LPXN | leupaxin | 0.040 | Human | |
| LAMB3 | laminin, beta 3 | 0.040 | Human | |
| JAG1 | jagged 1 | 0.039 | ||
| NCL | nucleolin | 0.039 | ||
| CAV2 | caveolin 2 | 0.039 | ||
| PGF | placental growth factor | 0.038 | Human | |
| PDLIM4 | PDZ and LIM domain 4 | 0.038 | ||
| SH2D1A | SH2 domain containing 1A | 0.038 | ||
| SMAD3 | SMAD family member 3 | 0.038 | Rat | |
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.037 | ||
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.037 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.037 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.036 | ||
| LAMC2 | laminin, gamma 2 | 0.036 | Human | |
| HNRPDL | heterogeneous nuclear ribonucleoprotein D-like | 0.036 | ||
| RBMX | RNA binding motif protein, X-linked | 0.036 | ||
| APC | adenomatous polyposis coli | 0.035 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.035 | ||
| AHNAK | AHNAK nucleoprotein | 0.035 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.035 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.034 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.034 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.034 | ||
| EFNA5 | ephrin-A5 | 0.033 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.033 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.032 | ||
| EED | embryonic ectoderm development | 0.032 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.032 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.031 | ||
| PHF21A | PHD finger protein 21A | 0.031 | ||
| TTN | titin | 0.031 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.031 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.031 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.031 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.031 | ||
| EPHB3 | EPH receptor B3 | 0.031 | Human | |
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.030 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.030 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.029 | ||
| PDIA4 | protein disulfide isomerase family A, member 4 | 0.029 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.028 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.028 | Worm | |
| SKIL | SKI-like oncogene | 0.028 | ||
| CTGF | connective tissue growth factor | 0.027 | ||
| ANXA5 | annexin A5 | 0.027 | ||
| HGS | hepatocyte growth factor-regulated tyrosine kinase substrate | 0.027 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.027 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.027 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.027 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.026 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.026 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.026 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.026 | ||
| PALLD | palladin, cytoskeletal associated protein | 0.026 | ||
| HNRNPH2 | heterogeneous nuclear ribonucleoprotein H2 (H') | 0.026 | ||
| BMP4 | bone morphogenetic protein 4 | 0.025 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.025 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.025 | ||
| ZNF512B | zinc finger protein 512B | 0.025 | ||
| S100P | S100 calcium binding protein P | 0.025 | Human | |
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.025 | Human | |
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.025 | ||
| ACTN4 | actinin, alpha 4 | 0.024 | Human | |
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.024 | Human | |
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.024 | ||
| VCL | vinculin | 0.024 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.024 | Rat | |
| TARDBP | TAR DNA binding protein | 0.024 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.024 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.023 | ||
| HMGN1 | high mobility group nucleosome binding domain 1 | 0.023 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.023 | ||
| NCK1 | NCK adaptor protein 1 | 0.023 | ||
| LIMK1 | LIM domain kinase 1 | 0.023 | ||
| COL17A1 | collagen, type XVII, alpha 1 | 0.022 | ||
| MYO9B | myosin IXB | 0.022 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.022 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.022 | Human | |
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.022 | ||
| FHL2 | four and a half LIM domains 2 | 0.022 | ||
| SNAPIN | SNAP-associated protein | 0.022 | ||
| BTBD2 | BTB (POZ) domain containing 2 | 0.022 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.022 | ||
| LAMA5 | laminin, alpha 5 | 0.021 | ||
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.021 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.021 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.020 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.020 | Human | |
| ATXN1 | ataxin 1 | 0.020 | ||
| PKP3 | plakophilin 3 | 0.020 | ||
| MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.020 | ||
| TRIM29 | tripartite motif containing 29 | 0.020 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.019 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.019 | ||
| EPHB2 | EPH receptor B2 | 0.019 | Human | |
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.019 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.019 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.019 | ||
| HDAC1 | histone deacetylase 1 | 0.019 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.019 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.019 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.019 | Worm | |
| AGER | advanced glycosylation end product-specific receptor | 0.019 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.018 | ||
| GATAD2B | GATA zinc finger domain containing 2B | 0.018 | ||
| CSNK1E | casein kinase 1, epsilon | 0.018 | ||
| MDFI | MyoD family inhibitor | 0.018 | ||
| BCL2L1 | BCL2-like 1 | 0.018 | ||
| PARVA | parvin, alpha | 0.018 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.018 | ||
| AGRN | agrin | 0.017 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.017 | ||
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.017 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.017 | Human | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.017 | ||
| NASP | nuclear autoantigenic sperm protein (histone-binding) | 0.017 | ||
| CLU | clusterin | 0.017 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.017 | ||
| PLXNA1 | plexin A1 | 0.017 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.017 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.017 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.017 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.016 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.016 | ||
| WT1 | Wilms tumor 1 | 0.016 | ||
| MEF2A | myocyte enhancer factor 2A | 0.016 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.016 | ||
| DCBLD1 | discoidin, CUB and LCCL domain containing 1 | 0.016 | ||
| CD34 | CD34 molecule | 0.016 | ||
| AMOTL2 | angiomotin like 2 | 0.016 | ||
| MED1 | mediator complex subunit 1 | 0.016 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.016 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.016 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.016 | ||
| TGFA | transforming growth factor, alpha | 0.016 | ||
| RHOU | ras homolog gene family, member U | 0.015 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.015 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.015 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.015 | ||
| SMAD9 | SMAD family member 9 | 0.015 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.015 | Human | |
| HNRNPR | heterogeneous nuclear ribonucleoprotein R | 0.015 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.015 | ||
| LNX1 | ligand of numb-protein X 1 | 0.015 | ||
| CADM4 | cell adhesion molecule 4 | 0.015 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.015 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.015 | ||
| S100A10 | S100 calcium binding protein A10 | 0.015 | ||
| EHD2 | EH-domain containing 2 | 0.015 | ||
| ILK | integrin-linked kinase | 0.015 | ||
| EFNB1 | ephrin-B1 | 0.015 | Human | |
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.015 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.015 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.014 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.014 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.014 | ||
| OBSL1 | obscurin-like 1 | 0.014 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.014 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.014 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.014 | ||
| PTEN | phosphatase and tensin homolog | 0.014 | ||
| SMAD6 | SMAD family member 6 | 0.014 | ||
| CIRBP | cold inducible RNA binding protein | 0.014 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.014 | ||
| FYB | FYN binding protein | 0.014 | ||
| PRKCSH | protein kinase C substrate 80K-H | 0.014 | ||
| SBF1 | SET binding factor 1 | 0.014 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.014 | ||
| DISC1 | disrupted in schizophrenia 1 | 0.014 | ||
| ESR1 | estrogen receptor 1 | 0.014 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.013 | ||
| EPHB4 | EPH receptor B4 | 0.013 | Human | |
| EPHA3 | EPH receptor A3 | 0.013 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.013 | ||
| DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 0.013 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.013 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.013 | ||
| KRT17 | keratin 17 | 0.013 | ||
| SDC1 | syndecan 1 | 0.013 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.013 | ||
| RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.013 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.013 | ||
| RHOA | ras homolog gene family, member A | 0.013 | ||
| MUC1 | mucin 1, cell surface associated | 0.013 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.013 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.013 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.013 | ||
| TSG101 | tumor susceptibility gene 101 | 0.013 | ||
| TCAP | titin-cap (telethonin) | 0.013 | ||
| SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0.013 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.013 | ||
| CBX7 | chromobox homolog 7 | 0.013 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.013 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.013 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.013 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.013 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.012 | ||
| SMTN | smoothelin | 0.012 | ||
| BCAM | basal cell adhesion molecule (Lutheran blood group) | 0.012 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.012 | ||
| LMOD1 | leiomodin 1 (smooth muscle) | 0.012 | ||
| MCAM | melanoma cell adhesion molecule | 0.012 | ||
| HECTD3 | HECT domain containing 3 | 0.012 | ||
| PLAU | plasminogen activator, urokinase | 0.012 | ||
| GJB3 | gap junction protein, beta 3, 31kDa | 0.012 | ||
| FSTL1 | follistatin-like 1 | 0.012 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.012 | ||
| NOTCH1 | notch 1 | 0.012 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.012 | ||
| TRIO | triple functional domain (PTPRF interacting) | 0.012 | ||
| PLAT | plasminogen activator, tissue | 0.012 | ||
| HMGB1 | high mobility group box 1 | 0.012 | ||
| EFNB2 | ephrin-B2 | 0.012 | Human | |
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.012 | ||
| BTBD7 | BTB (POZ) domain containing 7 | 0.012 | ||
| MYL9 | myosin, light chain 9, regulatory | 0.012 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.012 | ||
| ECE1 | endothelin converting enzyme 1 | 0.012 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.012 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.012 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.012 | ||
| FKBP9 | FK506 binding protein 9, 63 kDa | 0.011 | ||
| THBS1 | thrombospondin 1 | 0.011 | ||
| NRP2 | neuropilin 2 | 0.011 | ||
| OCLN | occludin | 0.011 | ||
| CDH13 | cadherin 13, H-cadherin (heart) | 0.011 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.011 | Mouse | |
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.011 | ||
| KLF10 | Kruppel-like factor 10 | 0.011 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.011 | ||
| CLDN1 | claudin 1 | 0.011 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.011 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.011 | ||
| S100A12 | S100 calcium binding protein A12 | 0.011 | Human | |
| ARHGEF17 | Rho guanine nucleotide exchange factor (GEF) 17 | 0.011 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.011 | ||
| FAM129B | family with sequence similarity 129, member B | 0.011 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.011 | ||
| SYDE1 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | 0.011 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.011 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.011 | ||
| EPHB6 | EPH receptor B6 | 0.011 | Human | |
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.011 | ||
| HOXA9 | homeobox A9 | 0.011 | ||
| MAPT | microtubule-associated protein tau | 0.011 | ||
| CBX8 | chromobox homolog 8 | 0.011 | ||
| ITGB5 | integrin, beta 5 | 0.011 | Human | |
| MRAS | muscle RAS oncogene homolog | 0.011 | ||
| S100A3 | S100 calcium binding protein A3 | 0.011 | Human | |
| MMP19 | matrix metallopeptidase 19 | 0.011 | ||
| TNC | tenascin C | 0.011 | ||
| MYBPH | myosin binding protein H | 0.011 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.011 | ||
| CSNK1G2 | casein kinase 1, gamma 2 | 0.011 | ||
| CFB | complement factor B | 0.011 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.011 | ||
| PRKD2 | protein kinase D2 | 0.011 | ||
| MAP2 | microtubule-associated protein 2 | 0.010 | ||
| MLF1IP | MLF1 interacting protein | 0.010 | ||
| EMP3 | epithelial membrane protein 3 | 0.010 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.010 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.010 | ||
| INHBB | inhibin, beta B | 0.010 | ||
| TNS1 | tensin 1 | 0.010 | Mouse | |
| CALR | calreticulin | 0.010 | Worm | |
| GFI1B | growth factor independent 1B transcription repressor | 0.010 | ||
| PLOD1 | procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 | 0.010 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.010 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.010 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.010 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.010 | ||
| FAM65A | family with sequence similarity 65, member A | 0.010 | ||
| FES | feline sarcoma oncogene | 0.010 | ||
| SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 | 0.010 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.010 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.010 | ||
| VEGFC | vascular endothelial growth factor C | 0.010 | Human | |
| KRT14 | keratin 14 | 0.010 | ||
| PHAX | phosphorylated adaptor for RNA export | 0.010 | ||
| CDCP1 | CUB domain containing protein 1 | 0.010 | ||
| C19orf6 | chromosome 19 open reading frame 6 | 0.010 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.010 | ||
| CRYAB | crystallin, alpha B | 0.010 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.010 | Human | |
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.010 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.010 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.010 | ||
| DNM1 | dynamin 1 | 0.010 | ||
| SELPLG | selectin P ligand | 0.010 | ||
| TLN1 | talin 1 | 0.010 | Mouse | |
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.010 | ||
| PRKCQ | protein kinase C, theta | 0.010 |